Pfizer, a major American pharmaceutical company, and Biontech, a German company, said they were able to confirm the safety and efficacy of children aged 12 to 15 years, who are not currently eligible for an emergency use authorization for the new coronavirus vaccine. It has announced that it has applied to US regulators to expand its license.
Vaccines developed by Pfizer and others are currently licensed for emergency use for children 16 and older, but clinical trials are being conducted so that they can be used by children under the age of 16.
As a result of a clinical trial of 12 to 15 years old released on the 31st of last month, no child in the vaccinated group developed an infection caused by the new coronavirus, and side reactions were also 16 to 25 years old. It is said to be in good agreement with what was seen in clinical trials involving age.
The company has announced that it has applied to US regulators to expand its license, saying it has been confirmed to be safe and effective for ages 12-15.
In the United States, vaccination of children is an issue for resuming face-to-face lessons at school, and CDC = Centers for Disease Control and Prevention Warrensky said in an interview with the American media on the 7th of this month, "FDA permission. If it comes out, it will be possible to inoculate 12 to 15 years old by the middle of next month. "